innovate.collaborate.change

the cancer collaborative
come on in

bridging science, policy and advocacy

how we’re different  the cancer collaborative is a hub for the cancer community. created to foster an environment of collaboration amongst science, policy and advocacy in order to make a meaningful contribution to cancer care.  our goal is to co-create and collaborate with stakeholders to proactively identify the challenges and opportunities, prioritize them and work together to make action-oriented changes on how cancer care is delivered in canada and beyond. better outcomes for cancer patients in canada can only be achieved when we let go of old ideologies- embracing innovation, encouraging collaboration, creating collective purpose and fundamentally changing. bold ideas and fuelling dialogues that adapt and adopt to shifting paradigms.
we can be the catalyst for change
EXPLORE THE CANCER COLLABORATIVE
our PROJECTS
car-t cell therapy
accelerating adoption through collaboration
car-t cell therapy has entered clinical practice.  such a paradigm-shifting and novel cancer therapy that relies on viral production, genetic- modification, cell expansion, quality control/quality analysis, as well as clinical application and toxicity management poses significant challenges to regulatory and reimbursement approval.  .
biosimilars
expanding access to create sustainability
biosimilar medicines represent a rapidly emerging field that can offer improved accessibility to medicines for patients at reduced expenditure for healthcare systems that are tackling issues of sustainability. the next two years will be important for biosimilars uptake and impact.  biosimilars uptake in oncology can positively impact the financial burden of healthcare systems with the cost savings being reallocated to improve overall health system outcomes, globally.

precision medicine

cracking the cancer code

precision medicine and biomarkers present an incredible opportunity to revolutionize health care. it has the potential to change the way we think about, identify and manage cancer care. the impact on both clinical research and patient care will grow as our understanding and technologies improve transforming the delivery of cancer care to benefit both patients and cancer care systems.

immuno-oncology
tipping pIOnt
immuno-oncology [IO] therapies continue to create breakthroughs however real world challenges and significant shifts in value across healthcare systems create barriers to access for patients.

managing innovation in oncology

catalysts for change in cancer care
the next decade in healthcare will look nothing like the last- oncology is experiencing a tidal wave of therapies and technologies that continues to profoundly change the way cancer is diagnosed, treated, and monitored. the arrival of novel and disruptive technologies, precision medicine and emerging technologies, will drive oncology onward and the decisions taken today will have an impact on the landscape over the next decade.  industry, regulators, HTA, pricing agencies, health care professionals, researchers and patient advocates must work together to address these challenges and create solutions to overcome these clinical, regulatory, reimbursement and policy hurdles.

capacity building

building better advocates

the cancer collaborative considers advocacy an important tool in improving cancer care at provincial, national and global levels and patient advocates who are well informed and who have a thorough understanding of the clinical and political landscape can better identify, shape and influence policy and develop effective advocacy strategies and communication with decision makers. strengthening their capacity to address québec specific challenges and opportunities, and to better understand, respond and engage within the pan-canadian environment to proactively engage in an effective and efficient manner.

EXPLORE THE EVENTS
our WEBINARs
LATEST POST
our BLOG

world cancer day #iamandiwill

this year marks the 20th celebration of world cancer day - it began with six cancer experts who convened in paris in 1999. with the year 2000 imminent, the group was determined that the global challenge of cancer would not be forgotten in the new century. as we...

LATEST PUBLICATION
our REPORTS

our REPORTs

Get our latest colab notebooks and briefs –>  MORE

CONTACT US

#cancercolab
#travelwithcolab

our ASCO20 EDITION notebook is out - read about practice changing trials and more here https://roomc.co/wp-content/uploads/ASCO20.pdf*

If you're living with #cancer and feel at a loss for resources, @cancercolab has your back. Check out the list here, which includes our COVID19 Stress Monitor. #COVID19nCancer #COVID19 #coronavirus https://roomc.co/covid-19-resources-for-cancer-patients/

Load More...